GlassScriptPhysician profile
Dana Deon Johnson
NPI 1831562834
$1,185.12
in general payments reported to CMS, 2019-2025
16 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.45 · 2022: $172 · 2023: $584 · 2024: $166 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $246.70 | 2022-2025 | Hawkone, Interstim |
| Axonics, INC. | $212.28 | 2023-2024 | Axonics, Bulkamid |
| Angiodynamics, INC. | $146.43 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $99.09 | 2025 | Cardiomems |
| Evoke Pharma, INC. | $96.77 | 2023 | Gimoti |
| Sumitomo Pharma America, INC. | $62.21 | 2023-2024 | Gemtesa |
| Tolmar Pharmaceuticals, INC. | $51.00 | 2022 | |
| Urogen Pharma, INC. | $44.88 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $42.23 | 2023 | Optimizer |
| Boston Scientific Corporation | $29.42 | 2025 | Axonics |
| Astellas Pharma US INC | $29.12 | 2022-2023 | Myrbetriq |
| Abbvie INC. | $28.08 | 2023 | |
| 180 Medical, INC. | $26.34 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $25.22 | 2024 | |
| Urovant Sciences INC | $24.47 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20.88 | 2025 | Barrigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.